Roger Murphy

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

Ian D. Davis, Weisan Chen, Heather Jackson et al. · Proceedings of the National Academy of Sciences · 2004 · 437 citations · Full text

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

Andrew M. Scott, Fook-Thean Lee, Niall C. Tebbutt et al. · Proceedings of the National Academy of Sciences · 2007 · 217 citations · Full text

Immunology, Dermatology, Immunotherapy +16

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.

Akiko Uenaka, Hisashi Wada, Midori Isobe et al. · PubMed · 2007 · 129 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +21

HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan

Shigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata et al. · Clinical Cancer Research · 2006 · 129 citations

Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel

Shinichi Kageyama, Shigehisa Kitano, Michiko Hirayama et al. · Cancer Science · 2008 · 127 citations · Full text